Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Sander · SciRah

Researcher profile · Semantic Scholar

S. Sander

Share profile

S. Sander — researcher profile on SciRah

h-index: 20
Works: 79
Citations: 1,938

Most-cited papers

Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States
W. Baker, Deborah A Cios, S. Sander, C. Coleman
2009Journal of Managed Care Pharmacy430 citations Open access
Semantic Scholar
Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis
Sachin A. Shah, S. Sander, C. White, M. Rinaldi +1 more
2007Lancet. Infectious Diseases (Print)200 citations Open access
Semantic Scholar
The impact of coenzyme Q10 on systolic function in patients with chronic heart failure.
S. Sander, C. Coleman, Aarti A. Patel, J. Kluger +1 more
2006Journal of Cardiac Failure162 citations
Semantic Scholar
Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin
M. Zálešák, K. Siu, Kevin M. Francis, Chen Yu +7 more
2013Circulation. Cardiovascular Quality and Outcomes151 citations Open access
Semantic Scholar
A meta-analysis of the vascular-related safety profile and efficacy of α-adrenergic blockers for symptoms related to benign prostatic hyperplasia
J. C. Nickel, S. Sander, T. Moon
2008International journal of clinical practice145 citations Open access
Semantic Scholar
Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Catherine J. Mercaldi, M. Ciarametaro, B. Hahn, G. Chalissery +4 more
2011Stroke86 citations Open access
Semantic Scholar
Long-Term Costs of Ischemic Stroke and Major Bleeding Events among Medicare Patients with Nonvalvular Atrial Fibrillation
Catherine J. Mercaldi, K. Siu, S. Sander, D. R. Walker +3 more
2012Cardiology Research and Practice55 citations Open access
Semantic Scholar
Development of a Conceptual Model of Adherence to Oral Anticoagulants to Reduce Risk of Stroke in Patients with Atrial Fibrillation
T. Brown, K. Siu, D. R. Walker, M. Pladevall-Vila +2 more
2012Journal of Managed Care Pharmacy52 citations Open access
Semantic Scholar
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study.
C. White, S. Sander, C. Coleman, R. Gallagher +5 more
2007Journal of the American College of Cardiology50 citations Open access
Semantic Scholar
Vascular Health and Risk Management Dovepress Costs and Outcomes of Noncardioembolic Ischemic Stroke in a Managed Care Population
N. Engel-Nitz, S. Sander, C. Harley, Gabriel Gomez Rey +1 more
48 citations
Semantic Scholar
Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis.
Deborah A Cios, W. Baker, S. Sander, O. Phung +1 more
2009American Journal of Health-System Pharmacy44 citations
Semantic Scholar
Impact of persistence with antiplatelet therapy on recurrent ischemic stroke and predictors of nonpersistence among ischemic stroke survivors
J. Burke, S. Sander, H. Shah, V. Zarotsky +1 more
2010Current Medical Research and Opinion42 citations
Semantic Scholar
Differences in All-Cause Health Care Utilization and Costs in a Type 2 Diabetes Mellitus Population with and Without a History of Cardiovascular Disease
S. Mehta, Sabyasachi Ghosh, S. Sander, E. Kuti +1 more
2018Journal of Managed Care & Specialty Pharmacy36 citations Open access
Semantic Scholar
Effect of Prophylactic Amiodarone on Clinical and Economic Outcomes After Cardiothoracic Surgery: A Meta-Analysis
E. L. Gillespie, C. Coleman, S. Sander, J. Kluger +2 more
2005The Annals of Pharmacotherapy36 citations
Semantic Scholar
Health Care Resource Utilization, Costs, and Persistence in Patients Newly Diagnosed as Having Nonvalvular Atrial Fibrillation and Newly Treated With Dabigatran versus Warfarin in the United States.
T. Bancroft, Jonathan G. Lim, Cheng Wang, S. Sander +1 more
2016Clinical Therapeutics30 citations Open access
Semantic Scholar
Readmission among hospitalized patients with nonvalvular atrial fibrillation.
Barbara H. Johnson, K. Smoyer-Tomic, K. Siu, D. R. Walker +5 more
2013American Journal of Health-System Pharmacy30 citations
Semantic Scholar
Patterns and predictors of use of warfarin and other common long-term medications in patients with atrial fibrillation.
Xue Song, S. Sander, H. Varker, A. Amin
2012American Journal of Cardiovascular Drugs29 citations
Semantic Scholar
Anticoagulant Use, the Prevalence of Bridging, and Relation to Length of Stay among Hospitalized Patients with Non-Valvular Atrial Fibrillation
K. Smoyer-Tomic, K. Siu, D. R. Walker, Barbara H. Johnson +3 more
2012American Journal of Cardiovascular Drugs25 citations Open access
Semantic Scholar
Identifying patients with benign prostatic hyperplasia through a diagnosis of, or treatment for, erectile dysfunction
K. McVary, K. Foley, S. Long, S. Sander +2 more
2008Current Medical Research and Opinion24 citations
Semantic Scholar
Efficacy and cost-effectiveness of dabigatran etexilate versus warfarin in atrial fibrillation in different age subgroups.
A. Clemens, S. Peng, S. Brand, M. Brueckmann +5 more
2014American Journal of Cardiology23 citations Open access
Semantic Scholar
Impact of atrial fibrillation and oral anticoagulation on hospital costs and length of stay.
Xue Song, S. Sander, Barbara H. Johnson, H. Varker +1 more
2012American Journal of Health-System Pharmacy20 citations
Semantic Scholar
Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population
V. Willey, J. Franchino-Elder, A. Fu, Cheng Wang +4 more
2018BMJ Open19 citations Open access
Semantic Scholar
Healthcare utilization and costs associated with dabigatran compared to warfarin treatment in newly diagnosed patients with non-valvular atrial fibrillation
Kevin M. Francis, Chen Yu, H. Alvrtsyan, S. Sander +4 more
2015Current Medical Research and Opinion19 citations
Semantic Scholar
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Shannon L Reynolds, S. Ghate, R. Sheer, P. Gandhi +6 more
2017Health and Quality of Life Outcomes15 citations Open access
Semantic Scholar
Health Care Utilization and Costs in Type 2 Diabetes Mellitus and Their Association with Renal Impairment
J. Burke, B. Kovacs, Leigh Borton, S. Sander
2012Postgraduate medicine15 citations
Semantic Scholar
Cardiovascular event incidence and cost in type 2 diabetes mellitus: a Medicare claims-based actuarial analysis
K. Fitch, Tyler Engel, S. Sander, E. Kuti +1 more
2017Current Medical Research and Opinion14 citations
Semantic Scholar
Clinical and economic outcomes associated with National Kidney Foundation guideline-concordant oral antidiabetic drug treatment among type 2 diabetes patients with chronic kidney disease
Shih-Yin Chen, K. Siu, B. Kovacs, M. Stokes +3 more
2012Current Medical Research and Opinion13 citations
Semantic Scholar
Comparison of all-cause costs and healthcare resource use among patients with newly-diagnosed non-valvular atrial fibrillation newly treated with oral anticoagulants
A. Gilligan, J. Franchino-Elder, Xue Song, Cheng Wang +5 more
2018Current Medical Research and Opinion12 citations
Semantic Scholar
All-Cause, Stroke-, and Bleed-Specific Healthcare Costs: Comparison among Patients with Non-Valvular Atrial Fibrillation (NVAF) Newly Treated with Dabigatran or Warfarin
A. Gilligan, P. Gandhi, Xue Song, Cheng Wang +3 more
2017American Journal of Cardiovascular Drugs11 citations Open access
Semantic Scholar
Hospital Admissions, Costs, and 30-Day Readmissions Among Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran Etexilate or Warfarin
Eileen V. Fonseca, S. Sander, G. Hess, Sabyasachi Ghosh
2015Journal of Managed Care & Specialty Pharmacy10 citations Open access
Semantic Scholar
Comparison of all-cause, stroke, and bleed-specific healthcare resource utilization among patients with non-valvular atrial fibrillation (NVAF) and newly treated with dabigatran or warfarin
Xue Song, P. Gandhi, A. Gilligan, P. Arora +4 more
2019Expert review of pharmacoeconomics & outcomes research9 citations
Semantic Scholar
Patterns and Predictors of Use of Warfarin and Other Common Long-Term Medications in Patients with Atrial Fibrillation
Xue Song, S. Sander, H. Varker, A. Amin
2012American Journal of Cardiovascular Drugs9 citations
Semantic Scholar
Delivery of esomeprazole magnesium through nasogastric and gastrostomy tubes using an oral liquid vehicle as a suspending agent in vitro.
Sachin A. Shah, S. Sander, C. Coleman, C. White
2006American Journal of Health-System Pharmacy9 citations
Semantic Scholar
Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States
R. Jain, A. Fu, Jonathan G. Lim, Cheng Wang +3 more
2018Journal of Managed Care & Specialty Pharmacy8 citations Open access
Semantic Scholar
costs and outcomes of noncardioembolic ischemic stroke in a managed care population
N. Engel-Nitz, S. Sander, C. Harley, G. G. Rey +1 more
20107 citations
Semantic Scholar
Factors influencing dabigatran or warfarin medication persistence in patients with nonvalvular atrial fibrillation.
S. Annavarapu, P. Gandhi, Yong Li, P. Arora +4 more
2018Journal of Comparative Effectiveness Research6 citations
Semantic Scholar
The cost of cardiovascular-disease-related death in patients with type 2 diabetes mellitus
S. Shetty, D. Stafkey-Mailey, Bing-Lin Yue, Anna D. Coutinho +4 more
2018Current Medical Research and Opinion5 citations
Semantic Scholar
Electrocardiographic and Hemodynamic Effects of Coenzyme Q10 in Healthy Individuals: A Double-Blind, Randomized Controlled Trial
Sachin A. Shah, S. Sander, Deborah A Cios, Jenny Lipeika +2 more
2007The Annals of Pharmacotherapy5 citations
Semantic Scholar
Abstract 242: Healthcare Resource Utilization and Costs among Patients with Non-Valvular Atrial Fibrillation using Dabigatran or Warfarin For Stroke Prevention
A. Fu, R. Jain, S. Sander, Jonathan G. Lim +3 more
2014Circulation: Cardiovascular Quality and Outcomes4 citations
Semantic Scholar
One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel
T. Burton, M. Lacey, Fang Liu, Yan-Ni F. Yu +3 more
2012Journal of Medical Economics4 citations Open access
Semantic Scholar
Comparison of stroke- and bleed-related healthcare resource utilization and costs among patients with newly diagnosed non-valvular atrial fibrillation and newly treated with dabigatran, rivaroxaban, or warfarin
A. Gilligan, J. Franchino-Elder, Xue Song, Cheng Wang +5 more
2018Expert review of pharmacoeconomics & outcomes research3 citations
Semantic Scholar
Economic analysis of a medication assistance program for ambulatory care patients at an urban teaching clinic
PharmDEffie L. Gillespie PharmD Effie L. Gillespie, Aarti A. Patel, S. Sander, C. Coleman +2 more
20063 citations
Semantic Scholar
Ximelagatran: A new oral anticoagulant
S. Sander, C. White
20043 citations
Semantic Scholar
Uninsured Chronic Hepatitis C Patients And Their Cost Implications Under The Affordable Care Act
J. Scaife, E. Kuti, L. Acampa, H. Alvrtsyan +6 more
20132 citations Open access
Semantic Scholar
Persistence Among Patients with Non-Valvular Atrial Fibrillation Beginning Dabigatran or Warfarin
Kevin M. Francis, K. Siu, Chen Yu, H. Alvrtsyan +6 more
20122 citations
Semantic Scholar
Impact of amiodarone on the ability of anterior fat pad retention to prevent postcoronary arterial bypass grafting atrial fibrillation incidence: a substudy of the AFIST III (Atrial Fibrillation Suppression Trial III)
C. Coleman, J. Kluger, Krista M. Dale, S. Sander +4 more
2008Expert Opinion on Pharmacotherapy2 citations
Semantic Scholar
Cost–effectiveness of antiplatelet therapy for secondary stroke prevention
Darya Malinina, C. Zema, S. Sander, V. Serebruany
2007Expert review of pharmacoeconomics & outcomes research2 citations
Semantic Scholar
Comparative Safety and Efficacy of Urokinase and Recombinant Tissue Plasminogen Activator for Peripheral Arterial Occlusion: A Meta‐Analysis
S. Sander, C. White, C. Coleman
2006Pharmacotherapy2 citations
Semantic Scholar
The use of prophylactic amiodarone after cardiothoracic surgery reduces the incidence of atrial fibrillation.
S. Sander, C. White
2005Connecticut medicine2 citations
Semantic Scholar
Incremental burden of type 2 diabetes in patients experiencing cardiovascular hospitalizations
Anna D. Coutinho, A. Raju, Weijia Wang, D. Stafkey-Mailey +2 more
2018Current Medical Research and Opinion1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Coleman×11
Invite
C. Coleman — researcher profile on SciRah
C. White×11
Invite
C. White — researcher profile on SciRah
Cheng Wang×9
Invite
Cheng Wang — researcher profile on SciRah
Xue Song×8
Invite
Xue Song — researcher profile on SciRah

×7

Invite

K. Siu — researcher profile on SciRah

David M. Smith×6

Invite

David M. Smith — researcher profile on SciRah

Invite

J. Kluger — researcher profile on SciRah

D. R. Walker×5

Invite

D. R. Walker — researcher profile on SciRah

Invite

A. Amin — researcher profile on SciRah

H. Alvrtsyan×4

Invite

H. Alvrtsyan — researcher profile on SciRah

Invite

H. Sanchez — researcher profile on SciRah

Jonathan G. Lim×4

Invite

Jonathan G. Lim — researcher profile on SciRah